Oncology Clinical Trials in Hartford, CT

As of August 2026, 54 paid clinical trials are recruiting for Oncology in Hartford, Connecticut. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 31, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

54 clinical trials for Oncology

·Clear filters·

Email me when a new oncology trial opens in Hartford, CT.

A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers

for Gastrointestinal Cancer

Sites in Hartford +7 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT05789485·Phase 2·Recruiting·Listed Mar 2023

Apply to this trial

Genomic Profiling in Cancer Patients

for Solid Tumors

Sites in Hartford, Bridgeport +16 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: All ages

Code: NCT01775072·Recruiting·Listed Jan 2013

Apply to this trial

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

for Neuroblastoma

Sites in Hartford +19 more locations

Sponsor: Giselle Sholler

Sex: All·Age: Up to 22

Code: NCT02559778·Phase 2·Recruiting·Listed Sep 2015

Apply to this trial

Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

for Rectal Adenocarcinoma

Sites in Hartford +9 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT04165772·Phase 2·Recruiting·Listed Nov 2019

Apply to this trial

Cryocompression to Reduce Chemotherapy-induced Peripheral Neuropathy in Gynecologic Cancer - COHORT 2

for Gynecologic Cancer

Sites in Hartford, Middletown +2 more locations

Sponsor: Duke University

Sex: Female·Age: 18+

Code: NCT06139458·Recruiting·Listed Nov 2023

Apply to this trial

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

for Neuroblastoma

Sites in Hartford +11 more locations

Sponsor: Giselle Sholler

Sex: All·Age: 1 - 21

Code: NCT06540963·Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

for Prostate Adenocarcinoma

Sites in Hartford, Glastonbury +130 more locations

Sponsor: SWOG Cancer Research Network

Sex: Male·Age: 18+

Code: NCT05806515·Phase 2·Recruiting·Listed Apr 2023

Apply to this trial

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

for Triple Negative Breast Cancer

Sites in Hartford, Norwalk +10 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT03808337·Phase 2·Recruiting·Listed Jan 2019

Apply to this trial

Beat Childhood Cancer Specimen Banking and Data Registry

for Pediatric Cancer

Sites in Hartford +16 more locations

Sponsor: Giselle Sholler

Sex: All·Age: All ages·Accepts healthy volunteers

Code: NCT04715178·Recruiting·Listed Jan 2021

Apply to this trial

Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

for Neuroblastoma

Sites in Hartford +5 more locations

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: Up to 17

Code: NCT06831552·Recruiting·Listed Feb 2025

Apply to this trial

Improving Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention

for Pediatric Cancer

1 location in Hartford

Sponsor: Connecticut Children's Medical Center

Sex: All·Age: 15 - 25

Code: NCT06982066·Recruiting·Listed May 2025

Apply to this trial

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for Rhabdomyosarcoma

Sites in Hartford +84 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 50

Code: NCT07466316·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

for Biliary Tract Cancer

Drug: Rilvegostomig

Sites in Hartford, New Haven +34 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07221253·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer

for Prostate Cancer

Sites in Hartford +9 more locations

Sponsor: City of Hope Medical Center

Sex: Male·Age: 18+

Code: NCT05751434·Phase 2·Recruiting·Listed Mar 2023

Apply to this trial

Conditions in Oncology (Hartford, CT)

Neuroblastoma· 8 Non-small cell lung cancer (NSCLC)· 7 Breast cancer· 6 Solid tumor· 6 Leukemia (other)· 5 Prostate cancer· 4 Pancreatic cancer· 3 Ovarian cancer· 3 Myelodysplastic syndromes (MDS)· 3 Osteosarcoma· 3 Metastatic breast cancer· 2 Lung cancer· 2 Biliary tract cancer· 2 Endometrial cancer· 2 Acute myeloid leukemia (AML)· 2 Myeloproliferative neoplasm· 2 Non-Hodgkin lymphoma· 2 Mantle cell lymphoma· 2 Ewing sarcoma· 2 Rhabdomyosarcoma· 2 Pediatric cancer· 2 Cancer (any)· 2 Triple-negative breast cancer· 1 HER2-positive breast cancer· 1 Esophageal cancer· 1 Gastrointestinal cancer· 1 Metastatic prostate cancer· 1 Bladder cancer· 1 Cervical cancer· 1 Gynecologic cancer· 1 Glioblastoma· 1 Glioma· 1 Multiple myeloma· 1 Acute lymphoblastic leukemia· 1 Myelofibrosis· 1 Follicular lymphoma· 1 Marginal zone lymphoma· 1 Hematologic malignancy· 1 Melanoma· 1 Head and neck cancer· 1 Mesothelioma· 1 Neuroendocrine tumors· 1